PRMT5 and laryngeal carcinoma: To investigate the potential effect of PRMT5 in laryngeal carcinoma, first, we examined the expression status of PRMT5 in laryngeal carcinoma cell lines, including Tu212, Tu686, M2e, M4e, and normal oral mucosa epithelial cell (NOK).